AC
IBB icon

AlphaCore Capital’s iShares Biotechnology ETF IBB Stock Holding History

AlphaCore Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$701K Sell
3,688
-1,030
-22% -$177K 0.01% 562
2026
Q1 		$797K Hold
4,718
– – 0.02% 438
2025
Q4 		$796K Buy
4,718
+3,891
+470% +$632K 0.02% 473
2025
Q3 		$119K Buy
827
+1
+0.1% +$136 ﹤0.01% 785
2025
Q2 		$105K Buy
826
+223
+37% +$27.4K ﹤0.01% 702
2025
Q1 		$77.2K Hold
603
– – 0.01% 550
2024
Q4 		$79.7K Hold
603
– – 0.02% 225
2024
Q3 		$87.7K Buy
603
+1
+0.2% +$145 0.02% 214
2024
Q2 		$82.6K Hold
602
– – 0.02% 200
2024
Q1 		$82.6K Sell
602
-302
-33% -$41.2K 0.02% 155
2023
Q4 		$123K Buy
904
+304
+51% +$37.1K 0.02% 244
2023
Q3 		$73.4K Hold
600
– – 0.01% 256
2023
Q2 		$76.2K Hold
600
– – 0.01% 230
2023
Q1 		$77.5K Hold
600
– – 0.02% 158
2022
Q4 		$78.7K Buy
600
+2
+0.3% +$258 0.03% 98
2022
Q3 		$70K Buy
598
+9
+2% +$1.12K 0.03% 80
2022
Q2 		$69K Hold
589
– – 0.03% 93
2022
Q1 		$77K Hold
589
– – 0.03% 90
2021
Q4 		$90K Buy
589
+1
+0.2% +$155 0.04% 61
2021
Q3 		$95K Hold
588
– – 0.05% 66
2021
Q2 		$96K Buy
588
+1
+0.2% +$154 0.05% 49
2021
Q1 		$88K Sell
587
-176
-23% -$28K 0.06% 36
2020
Q4 		$116K Hold
763
– – 0.09% 37
2020
Q3 		$103K Hold
763
– – 0.09% 37
2020
Q2 		$104K Buy
763
+2
+0.3% +$255 0.1% 38
2020
Q1 		$82K Hold
761
– – 0.06% 83
2019
Q4 		$92K Buy
+761
New +$84.9K 0.06% 81

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

AlphaCore Capital's IBB Position: Q2 2026 in Review

AlphaCore Capital reduced its iShares Biotechnology ETF (IBB) stake by 22% in Q2 2026, selling an estimated $177K and leaving 3,688 shares worth $701K. The position accounts for 0.01% of the portfolio, ranked #562.

AlphaCore Capital first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. The position peaked at $797K in Q1 2026. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • AlphaCore Capital held 3,688 shares of iShares Biotechnology ETF worth $701K as of Q2 2026.
  • AlphaCore Capital sold 1,030 iShares Biotechnology ETF shares in Q2 2026, an estimated $177K.
  • iShares Biotechnology ETF made up 0.01% of AlphaCore Capital's portfolio in Q2 2026, its #562 holding.
  • AlphaCore Capital first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
  • AlphaCore Capital's iShares Biotechnology ETF position peaked at $797K in Q1 2026.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.